T-705a Multicenter Study in Adults Subjects With Uncomplicated Influenza
NCT01728753 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 550
Last updated 2015-10-21
Summary
This is safety and pharmacokinetics (PK) of favipiravir study in adults 18-80 years of age diagnosed with uncomplicated influenza.
Conditions
Interventions
- DRUG
-
Placebo BID x 1 day, and Placebo BID x 4 days; Placebo TID x 1 day, and Placebo TID x 4 days
- DRUG
-
Favipiravir
1200 mg TID on Day 1, then 600 mg TID on Days 2-5
- DRUG
-
Favipiravir
2400 mg loading dose followed by 600 mg + 600 mg on Day 1, then 600 mg TID on Days 2-5
- DRUG
-
Favipiravir
1800 mg BID on Day 1, then 800mg BID for Days 2 5
Sponsors & Collaborators
-
United States Department of Defense
collaborator FED -
MDVI, LLC
lead INDUSTRY
Principal Investigators
-
Jason M Hafizullah, MD · Sunrise Medical Research, Lauderdale Lakes, FL 33319
-
Susan Hole, D.O. · Riverside Clinical Research, Edgewater, FL 32132
-
Richard L. Beasley, MD · Health Concepts, Rapid City, SD 57702
-
Jay H Sandberg, DO · Oakland Medical Research Center, Troy, MI 48085
-
Edgardo A. Osea, MD · Holy Trinity Medical Clinic, Harbor City, CA 90710
-
Shawn N. Gentry, MD · HCCA Clinical Research Solutions, Columbia, TN 38401
-
Stephen K. Smith, MD · Burke Primary Care, Morganton, NC 28655
-
Roberto Sotolongo, MD · Research Institute of South Florida, Inc., Miami, FL 33173
-
Marina Raikhel, MD · Torrance Clinical Research Institute Inc., Lomita, CA 90717
-
Syed M. Rehman, MD · Asthma & Allergy Center, Toledo, OH 43617
-
Jeffrey Lenz, MD · Integrated Clinca Trial Services Inc., West Des Moines, IA 50265
-
Jorge L. Santander, MD · APF Research LLC, Miami, FL 33135
-
James A. Cervantes, MD · Meridian Clinical Research, Bellevue, NE 68005
-
Hipolito G. Mariano Jr., MD · Research Center of Fresno, Inc., Fresno, CA 93726
-
John M. Wise, MD · Field of Dreams PC, dba Bozeman Urgent Care Center, Bozeman, MT 59715
-
Mercedes B. Samson, MD · Associated Pharmaceutical Research Center, Inc., Buena Park, CA 90620
-
Shaukat A. Shah, MD · St. Joseph's Medical Associates, Stockton, CA 95204
-
Darin Gregory, MD · Pioneer Clinical Research LLC, Bellevue, NE 68005
-
Sandra M. Gawchik, DO · Asthma and Allergy Research Associates, Upland, PA 19013
-
Tiffany M. Pluto, DO · Fay West Family Practice, Scottdale, PA 15683
-
Rennee N. Dhillon, MD · HCCA Clinical Research Solutions, Franklin, TN 37067
-
Almena L. Free, MD · Pinnacle Research Group LLC, Anniston, AL 36207
-
Esperanza Arce-Nunez, MD · South Florida Research Phase I-IV, Inc., Miami, FL 33165
-
Robert D. Rosen, MD · Clinical Trials of America, Inc., Winston Salem, NC 27103
-
Charles M. Schwarz, MD · Lovelace Scientific Resources, Inc., Venice, FL 34292
-
Idalia A. Acosta, MD · San Marcus Research Clinic Inc., Miami, FL 33015
-
Kishor E. Joshi, MD · Cherry Tree Medical Associates/Alternative Clinical Trials LLC, Uniontown, PA 15401
-
Patricia D. Salvato, MD · Diversified Medical Practices, P.A., Houston, TX 77057
-
Lawrence P. Schwartz, MD · HCCA Clinical Research Solutions, New York, NY 10016
-
Michael C. Hagan, MD · Montana Health Research Institute Inc., Billings, MT 59102
-
Martin J. Schear, MD · Dayton Clinical Research, Dayton, OH 45406
-
Stephen Ong, MD · MD Medical Research, Oxon Hill, MD 20745
-
April Palmer, MD · Clinical Trials Of America Inc., Shreveport, LA 71105
-
Derek D. Muse, MD · Highland Clinical Research, Salt Lake City, UT 84124
-
Jose M. Carpio, MD · The Community Research of South Florida, Hialeah, FL 33016
-
Thomas M Birch, MD · Holy Name Medical Center, Teaneck, NJ 07666
-
Barry K McLean, MD · Cahaba Research, Birmingham, AL 35242
-
Barry N Heller, MD · Novo Research Inc., Highland Heights, KY 41076
-
Karl V Sitz, MD · Little Rock Allergy & Asthma Clinical Research Center, Little Rock, AR 72205
-
Thomas C Nilsson, MD · Midwest Allergy and Asthma Clinic, P.C., Omaha, NE 68130
-
Douglas W Mapel, MD · Clinical Trial Connection, Flagstaff, AZ 86001
-
Ronald G DeGarmo, DO · DeGarmo Institute of Medical Research, Greer, SC 29651
-
Teresa S Sligh, MD · Providence Clinical Research, North Hollywood, CA 91606
-
Gary L Sutter, MD · HealthCare Partners Medical Group LLC, Los Angeles, CA 90015
-
John P Delgado, MD · Integrated Medical Research, PC, Ashland, Oregon 97520
-
Ronald K Stegemoller, MD · American Health Network of IN, LLC, Avon, IN 46123
-
Edgar A Marin, MD · Global Clinical Professionals, Miami, FL 33156
-
Marie R Albert, DO · Acadia Clinical Research, LLC, Bangor, Maine 04401
-
Mark A Turner, MD · Advanced Clinical Research Inc., Meridian, ID 83642
-
Terry L Poling, MD · Heartland Research Associates, LLC, Wichita, KS 67207
-
David R Hassman, DO · Comprehensive Clinical Research, Berlin, NJ 08009
-
William C Simon, DO · Professional Research Network of Kansas, LLC, Wichita, KS 67203
-
Brian K Allen, DO · University of Wisconsin La Crosse, La Crosse, WI 54601
-
Ernest L Hendrix, MD · North Alabama Research Center LLC, Athens, Alabama 35611
-
John A Panuto, MD · HCCA Clinical Research Solutions, Middleburg Heights, OH 44130
-
Sadia Dar, MD · HCCA Clinical Research Solutions, Smyrna, TN 37167
-
Michael E Hodges, MD · North Central Arkansas Medical Associates, Mountain Home, AZ 72653
-
Melanie Hoppers, MD · Physicians Quality Care, Jackson, TN 38305
-
Khai S Chang, MD · Lakeview Medical Research, Summerfield, FL 34491
-
Arles Perdomo, MD · Best Quality Research, Hialeah, FL 33016
-
Neerja Misra, MD · Quick Care Medical, Hamilton, NJ 08690
-
Steve Choi, MD · Urgent Care Specialist, LLC DBA Hometown Urgent Care & Occupational Health, Dayton, OH 45432
-
Gregory Pokrywka, MD · IRC Clinics, Towson, MD 21204
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-11-30
- Primary Completion
- 2013-02-28
- Completion
- 2013-02-28
Countries
- United States
Study Locations
More Related Trials
-
A Study to Evaluate the Efficacy and Safety of Intravenous Peramivir in Subjects With Uncomplicated Influenza.
NCT01224795 ·Status: TERMINATED ·Phase: PHASE3
-
Safety and Dose Study of Peramivir for Influenza Treatment
NCT00297050 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of the Efficacy and Safety of Peramivir in Subjects With Uncomplicated Acute Influenza.
NCT00419263 ·Status: COMPLETED ·Phase: PHASE2
-
Zanamivir Versus Trivalent Split Virus Influenza Vaccine
NCT00784784 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase II, Multicenter, Randomized, Placebo -Controlled, Study To Evaluate The Efficacy and Safety Of Intramuscular Peramivir 600 mg In Subjects With Uncomplicated Acute Influenza
NCT00705406 ·Status: COMPLETED ·Phase: PHASE2
-
Testing the AVI-7100 Flu Drug in Healthy Volunteers
NCT01747148 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluating the Use of Oseltamivir for the Treatment of Influenza in Adults
NCT01314911 ·Status: COMPLETED ·Phase: NA
-
Safety And Pharmacokinetics Study Of PF-04287881 In Healthy Adults
NCT00793000 ·Status: COMPLETED ·Phase: PHASE1
-
Safety Study of Single Administration Intravenous Treatment for Influenza
NCT01375985 ·Status: TERMINATED ·Phase: PHASE1
-
Study of Efficacy and Safety of TL-FVP-t vs. SOC in Patients With Mild to Moderate COVID-19
NCT04501783 ·Status: COMPLETED ·Phase: PHASE3
-
Intramuscular Peramivir for the Treatment of Uncomplicated Influenza
NCT00486980 ·Status: WITHDRAWN ·Phase: PHASE3
-
Comparing the Efficacy, Safety, and Tolerability of Combination Antivirals (Amantadine, Ribavirin, Oseltamivir) Versus Oseltamivir for the Treatment of Influenza in Adults at Risk for Complications
NCT01227967 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Investigate the Safety, Tolerability, and Pharmacokinetics (PK) of Oseltamivir and Its Carboxylate Metabolite, RO0640802 in Healthy Participants
NCT02717754 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Efficacy and Safety of IV Peramivir in Addition to Standard of Care Compared to Standard of Care Alone in Adults and Adolescents Who Are Hospitalized Due to Influenza
NCT00958776 ·Status: TERMINATED ·Phase: PHASE3
-
Dose Range Study to Evaluate the Efficacy and Safety of AV5080 in Patients With Influenza
NCT05095545 ·Status: COMPLETED ·Phase: PHASE2
-
A Pharmacokinetics Study of Favipiravir in Patients With Severe Influenza
NCT03394209 ·Status: COMPLETED ·Phase: PHASE2
-
Intramuscular Peramivir in Subjects With Uncomplicated Acute Influenza
NCT00610935 ·Status: TERMINATED ·Phase: PHASE3
-
Study Evaluating the Efficacy and Safety of AV5080 in Patients With Uncomplicated Influenza
NCT05093998 ·Status: UNKNOWN ·Phase: PHASE3
-
Study of Acute Uncomplicated Seasonal Influenza A in Adult Subjects
NCT02342249 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Intravenously Administered Tamiflu (Oseltamivir) in Patients Over 13 Years of Age With Influenza
NCT01050257 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Intravenous Zanamivir Versus Oral Oseltamivir in Adults and Adolescents Hospitalized With Influenza
NCT01231620 ·Status: COMPLETED ·Phase: PHASE3
-
Phase 2B Study on Safety and Therapeutic Efficacy of DAS181 in Adult Subjects With Naturally Acquired Influenza
NCT01740063 ·Status: COMPLETED ·Phase: PHASE2
-
Oral Favipiravir Compared to Placebo in Subjects With Mild COVID-19
NCT04346628 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Pharmacokinetics Study of FBF001
NCT02295813 ·Status: COMPLETED ·Phase: PHASE1
-
Philippine Trial to Determine Efficacy and Safety of Favipiravir for COVID-19
NCT05014373 ·Status: UNKNOWN ·Phase: PHASE3